Cargando…
Active Surveillance in Intermediate-Risk Prostate Cancer: A Review of the Current Data
SIMPLE SUMMARY: AS is an option for the initial management of selected patients with intermediate-risk PC. The proper way to predict which men will have an aggressive clinical course or indolent PC who would benefit from AS has not been unveiled. Genetics and MRI can help in the decision-making, but...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454661/ https://www.ncbi.nlm.nih.gov/pubmed/36077698 http://dx.doi.org/10.3390/cancers14174161 |